StonvexLoading…
StonvexStonvexStonvexCore line items from REYN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.72B | $3.69B | $3.76B | $3.82B |
Operating Income | $393.00M | $451.00M | $393.00M | $338.00M |
Net Income | $301.00M | $352.00M | $298.00M | $258.00M |
EPS (Diluted) | $1.43 | $1.67 | $1.42 | $1.23 |
Total Assets | $4.94B | $4.87B | $4.78B | $4.93B |
Total Liabilities | $2.68B | $2.73B | $2.80B | $3.06B |
Cash & Equivalents | $147.00M | $137.00M | $115.00M | $38.00M |
Free Cash Flow OCF − CapEx | $316.00M | $369.00M | $540.00M | $91.00M |
Shares Outstanding | 210.30M | 210.30M | 210.20M | 210.00M |